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A recent survey shows that diabetes affect 92.4 million 
people in mainland China [1], among which 16.9 million 
have diabetic retinopathy (DR) [2]. DR is one of the major 
causes of blindness in the working age population in both 
developing and developed countries. Although the exact 
mechanism by which diabetes causes retinopathy remains 
elusive, several hypotheses have been postulated to explain 
pathogenies of the disease. Here we invited five groups of 
scientists and clinicians to share their recent discoveries and 
expert opinions in molecular biology, pathophysiology, ge-
netics, and epigenetics of DR.  
Retinal angiogenesis is a hallmark of ischemic retinopa-
thy in DR. Exchange proteins directly activated by cAMP 
(Epacs, namely Epac1 and Epac2) are important cAMP me-
diators that play crucial roles in maintenance of endothelial 
barrier and neuronal functions. However, functional roles of 
Epac1 and Epac2 remain to be determined. By transient 
occlusion of middle cerebral artery on Epac1- and 
Epac2-deficient mice, Liu and colleagues [3] demonstrated 
that Epac2 ipsilateral retinas showed more neuronal cell 
loss in ganglion cell layer, increased retinal thickness and 
stronger immunostaining of AQP4, GFAP, and Prx6 than 
those of Epac2+/+. Whereas Epac1 ipsilateral retinae dis-
played similar pathology as those in Epac1+/+ mice. Togeth-
er, they demonstrated that Epac2-deficiency led to more 
severe ischemic retinopathy after the injury. On the other 
hand, the apelin and apelin receptor (APJ) system is known 
to cause endothelium-dependent vasodilatation and to be 
involved in angiogenesis. Microglial cells are major com-
ponents of the immune system in the retina. Diabetic injury 
triggers these cells to release inflammatory cytotoxins 
that lead to neuronal and vascular cell death and develop 
diabetic retinopathy. However, it remains to be demon-
strated if the activation of the inflammatory cytokines could 
be stimulated by apelin. Chen and colleagues [4] demon-
strated that inflammatory cytokines secretion can be regu-
lated by apelin stimulation. DR has a complex pathology 
that involves the vasculature of the inner retina and break-
down of the blood-retinal barrier. Barber [5] provided ex-
tensive evidence that DR is not only a vascular disease but 
also has a neurodegenerative component and that essentially 
all types of cells in the retina are affected, leading to chronic 
loss of visual function. Barber summarized recent develop-
ments in research towards understanding the complexities 
of retinal neurodegeneration occurring in DR, with neuronal 
loss, edema, glial cell reactivity and oxidative stress often 
observed. Indeed, in agreement with Barber’s postulation, 
Zhu and coworkers [6] provided clinical evidence that type 
2 diabetic patients without clinical evidence of diabetic ret-
inopathy showed significantly decreased superior macular 
ganglion cell complex thicknesses in diabetic cases but no 
significant peripapillary retinal nerve fiber layer thickness 
changes were observed. The contrast sensitivities at all 
space frequencies were significantly different between dia-
betic patients and controls. In the diabetic group, average 
superior ganglion cell complex thicknesses positively cor-
related with both contrast sensitivities at high spatial fre-
quencies and P50 amplitudes. These results suggest that 
ganglion cell complex thickness and visual function chang-
es could be observed in diabetic subjects before the onset of 
any significant diabetic retinopathy. Despite cutting edge  
research in the field, how retina and its vasculature are 
damaged by the diabetic milieu remains to be explored. 
520 Pu ML   Sci China Life Sci   June (2015) Vol.58 No.6 
Kowluru and Mishra [7] suggested that the environmental 
factors, life style or disease process can also bring in modi-
fications in the DNA, and these epigenetic modifications 
either silence or activate a gene without altering the DNA 
sequence. They discussed that diabetic environment regu-
lates a number of genes in the retina, and a large body of 
evidence has shown that it also facilitates epigenetic modi-
fications. Together, with epigenetic modifications taking an 
important place in diabetic retinopathy, they emphasize that 
it is now critical to investigate these epigenetic modifica-
tions, and understand their impact on this slowly progressed 
retinal disease.  
Together, these results of laboratory and clinical investi-
gations and expert opinions help us to better understand 
pathogenesis of DR. 
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